Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells
Rushworth, Stuart A, Pillinger, Genevra, Abdul-Aziz, Amina, Piddock, Rachel, Shafat, Manar S, Murray, Megan Y, Zaitseva, Lyubov, Lawes, Matthew J, MacEwan, David J, Bowles, Kristian MVolume:
2
Language:
english
Journal:
The Lancet Haematology
DOI:
10.1016/s2352-3026(15)00046-0
Date:
May, 2015
File:
PDF, 701 KB
english, 2015